Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Webcast: How to improve the patient journey through an effective engagement and activation strategy

April 24, 2023 | Patient journey, Patient research, Webcast, patient activation, patient engagement 

Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.

The global pandemic has caused the health and life science industry to change more in the last three years than it has in the last three decades. The accelerated adoption of digital in all areas of the healthcare landscape has dramatically altered the patient journey.  Now more than ever, healthcare stakeholders need support from pharma to help deliver optimal care to patients.  But are current engagement strategies working as well as they could be?

Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.

Using a typical product profile scenario in an area of high unmet need, they will demonstrate how pharmaceutical manufacturers can improve the patient journey through a combination of insight generation, engagement strategy and activation.

Research Partnership Director, Liza Pliss was joined by Nareda Mills, Global President, Patient Solutions at Ashfield Engage and Edward Gajewski, Principal at Nuvera Life Science Consulting.

They will share best-practice and practical insight on how to develop suitable research programs, strategies and initiatives that successfully support stakeholders throughout the journey, improve brand engagement and ultimately improve patient outcomes.

What you will learn:

  • How to gather the right insights for early commercialization and to guide the design of clinical trials
  • How to gain a foundational patient understanding in a new disease area or for a new asset in an area of unmet need
  • How to get a deeper understanding of the changing emotional needs of patients and their new digital behaviours in areas of chronic illness
  • How to deploy engagement tactics throughout the journey and product lifecycle

Watch here

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.